<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>DAVID GLUCK, MD - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/137793.xml</link>
<description>DAVID GLUCK, MD - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>A New Version of an Old Drug Successfully Treats Deadly Diseases Like HIV/AIDS, Cancer and MS in an Entirely New Way, by Strengthening the Immune System</title>
     <link>http://www.prweb.com/releases/2005/04/prweb230084.htm</link><description>   <![CDATA[ <P>Summary: A very low dose of the FDA-approved drug naltrexone has been discovered to be an effective up-regulator of the immune system. The new therapy, called low dose naltrexone (LDN), has shown remarkable effects on an array of illnesses including HIV/AIDS, cancer, and autoimmune diseases such as MS. The first conference concerning LDN will be held on June 11th at the New York Academy of Sciences in Manhattan. Recent clinical trials of LDN will be discussed. (PRWeb Apr 18, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/04/prweb230084.htm">http://www.prweb.com/releases/2005/04/prweb230084.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/04/prweb230084.htm</guid>
        </item>
</channel>
</rss>